This is a Demo Server. Data inside this system is only for test purpose.
 

Therapeutic potentials of inhibition of jumonji C domain-containing demethylases in acute myeloid leukemia;

dc.contributor.author Koca,D.
dc.contributor.author Hastar,N.
dc.contributor.author Engür,S.
dc.contributor.author Kiraz,Y.
dc.contributor.author Ulu,G.T.
dc.contributor.author Çekdemir,D.
dc.contributor.author Baran,Y.
dc.date.accessioned 2023-11-18T10:07:35Z
dc.date.available 2023-11-18T10:07:35Z
dc.date.issued 2020
dc.description.abstract Objective: Acute myeloid leukemia (AML) is a complex disease affected by both genetic and epigenetic factors. Histone methylation and demethylation are types of epigenetic modification in chromatin remodeling and gene expression. Abnormal expression of histone demethylases is indicated in many types of cancer including AML. Although many commercial drugs are available to treat AML, an absolute cure has not been discovered yet. However, inhibition of demethylases could be a potential cure for AML. Methylstat is a chemical agent that inhibits the Jumonji C domain-containing demethylases. Materials and Methods: The cytotoxic and apoptotic effects of methylstat and doxorubicin on HL-60 cells were detected by MTT cell viability assay, double staining of treated cells with annexin-V/ propidium iodide, and caspase-3 activity assay. Mitochondrial activity was analyzed using JC-1 dye. The expression levels of the BCL2 and BCL2L1 anti-apoptotic genes in HL-60 cells were determined using real-time polymerase chain reaction (PCR). Lastly, the cytostatic effect was determined by cell cycle analysis. Results: In our research, cytotoxic, cytostatic, and apoptotic effects of methylstat on human HL-60 cells were investigated. Cytotoxic and cytostatic analyses revealed that methylstat decreased cell proliferation in a dose-dependent cytotoxic manner and arrested HL-60 cells in the G2/M and S phases. Methylstat also induced apoptosis through the loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity. The expression levels of BCL2 and BCL2L1 were also decreased according to real-time PCR results. Finally, the combination of methylstat with doxorubicin resulted in synergistic cytotoxic effects on HL-60 cells. Conclusion: Taken together, these results demonstrate that methylstat may be a powerful candidate as a drug component of AML treatment protocols. © 2020 by Turkish Society of Hematology. en_US
dc.description.sponsorship Oxford University; Türkiye Bilimsel ve Teknolojik Araştirma Kurumu, TÜBITAK, (DEB 2209-A) en_US
dc.identifier.citation 2
dc.identifier.doi 10.4274/tjh.galenos.2019.2019.0083
dc.identifier.issn 1300-7777
dc.identifier.scopus 2-s2.0-85080841319
dc.identifier.uri https://doi.org/10.4274/tjh.galenos.2019.2019.0083
dc.identifier.uri http://standard-demo.gcris.com/handle/123456789/7072
dc.language.iso en en_US
dc.publisher Turkish Society of Hematology en_US
dc.relation.ispartof Turkish Journal of Hematology en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Acute myeloid leukemia en_US
dc.subject Histone methylation en_US
dc.subject Jumonji C domain en_US
dc.subject Methylstat en_US
dc.title Therapeutic potentials of inhibition of jumonji C domain-containing demethylases in acute myeloid leukemia; en_US
dc.title.alternative Akut myeloid lösemide demetilaz içeren jumanji C domainin inhibisyonunun terapötik potansiyeli en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.description.department Izmir Institute of Technology İYTE en_US
gdc.description.departmenttemp Koca D., İzmir Institute of Technology, Department of Molecular Biology and Genetics, İzmir, Turkey; Hastar N., İzmir Institute of Technology, Department of Molecular Biology and Genetics, İzmir, Turkey; Engür S., Anadolu University, Faculty of Pharmacy, Department of Pharmacology, Eskişehir, Turkey; Kiraz Y., İzmir Institute of Technology, Department of Molecular Biology and Genetics, İzmir, Turkey; Ulu G.T., İzmir Institute of Technology, Department of Molecular Biology and Genetics, İzmir, Turkey; Çekdemir D., Sakarya University, Faculty of Medicine, Department of Hematology, Sakarya, Turkey; Baran Y., İzmir Institute of Technology, Department of Molecular Biology and Genetics, İzmir, Turkey en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.volume 37 en_US
gdc.identifier.pmid PubMed:31833715
gdc.oaire.accepatencedate 2019-12-13
gdc.oaire.accesstype Gold
gdc.oaire.diamondjournal FALSE
gdc.oaire.downloads 163
gdc.oaire.impulse 1
gdc.oaire.influence 3.02E-09
gdc.oaire.influencealt 1
gdc.oaire.isgreen TRUE
gdc.oaire.keywords Jumonji Domain-Containing Histone Demethylases
gdc.oaire.keywords Antineoplastic Agents
gdc.oaire.keywords Apoptosis
gdc.oaire.keywords acute myeloid leukemia
gdc.oaire.keywords Methylation
gdc.oaire.keywords methylstat
gdc.oaire.keywords Histones
gdc.oaire.keywords Cell Line, Tumor
gdc.oaire.keywords Biomarkers, Tumor
gdc.oaire.keywords Humans
gdc.oaire.keywords Diseases of the blood and blood-forming organs
gdc.oaire.keywords Protein Interaction Domains and Motifs
gdc.oaire.keywords histone methylation
gdc.oaire.keywords Molecular Targeted Therapy
gdc.oaire.keywords Membrane Potential, Mitochondrial
gdc.oaire.keywords Dose-Response Relationship, Drug
gdc.oaire.keywords Caspase 3
gdc.oaire.keywords Cell Cycle
gdc.oaire.keywords jumonji c domain
gdc.oaire.keywords Matrix Metalloproteinases
gdc.oaire.keywords Gene Expression Regulation, Neoplastic
gdc.oaire.keywords Leukemia, Myeloid, Acute
gdc.oaire.keywords RC633-647.5
gdc.oaire.keywords Research Article
gdc.oaire.magid 2999608793
gdc.oaire.popularity 3.29E-09
gdc.oaire.popularityalt 0.6
gdc.oaire.publicfunded FALSE
gdc.oaire.relevantdates created:2019-12-13
gdc.oaire.relevantdates published-online:2019-12-13
gdc.oaire.relevantdates issued:2020-01-01
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 030104 developmental biology
gdc.oaire.views 132
gdc.opencitations.count 1
gdc.plumx.mendeley 7
gdc.plumx.scopuscites 2
gdc.scopus.citedbycount 3
gdc.sobiad.citedbycount 0
relation.isAuthorOfPublication 284ecb77-30bf-4d4d-a1b9-c35c6e2c8434
relation.isAuthorOfPublication.latestForDiscovery 284ecb77-30bf-4d4d-a1b9-c35c6e2c8434

Files

Collections